Literature DB >> 20084420

Amputation of uterine corpus as the intraoperative modification during cesarean radical hysterectomy for invasive cervical cancer during pregnancy.

Koji Matsuo1, Takayuki Enomoto, Masato Yamasaki.   

Abstract

OBJECTIVE: Cesarean radical hysterectomy (CRH) for invasive cervical cancer during pregnancy is characterized by heavy blood loss. Any surgical modifications made in an attempt to reduce the blood loss are valuable. Our study was designed to evaluate the efficacy of amputating the uterine corpus during CRH.
METHODS: All cases of radical hysterectomy (RH) were evaluated. Cases were divided into: (a) cesarean section immediately followed by RH for invasive cervical cancer complicating pregnancy (CRH group); and (b) RH for nonpregnant subjects (RH group). The information abstracted included estimated blood loss (EBL), operative time, intraoperative transfusion, and use of amputation of uterine corpus during CRH. Nonparametric tests were used for the statistical analysis.
RESULTS: There were five CRH cases (3 for CRH with amputation, 2 for CRH without amputation) and 209 RH cases were evaluated for statistics during the study period. The difference in mean operative time between the CRH group and the RH group was not statistically significant: 276.6 min (range 160-425) versus 297.3 min (range 147-645), p = 0.66. The mean EBL for the CRH group was significantly larger than that for the RH group: 2106.6 ml (range 730-4150) versus 858.8 ml (range 150-4770), p < 0.001. Mean operative time and mean EBL for CRH with amputation of uterine corpus were significantly less than those for CRH without amputation of uterine corpus: operative time, 186.0 min (range 160-228) versus 412.5 min (range 400-425), p = 0.043; EBL, 1034.3 ml (range 730-1540) versus 3715.0 ml (range 3280-4150), p = 0.043. No intraoperative tumor exposures were observed in the amputated cases.
CONCLUSION: Amputation of uterine corpus during CRH for invasive cervical cancer during pregnancy significantly improves the intraoperative performance, although it should be used with care.

Entities:  

Mesh:

Year:  2010        PMID: 20084420     DOI: 10.1007/s10147-009-0014-4

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  12 in total

1.  Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes.

Authors:  A K Sood; J I Sorosky; N Mayr; B Anderson; R E Buller; J Niebyl
Journal:  Obstet Gynecol       Date:  2000-06       Impact factor: 7.661

Review 2.  Management of stage I cervical cancer in pregnancy.

Authors:  C Nguyen; F J Montz; R E Bristow
Journal:  Obstet Gynecol Surv       Date:  2000-10       Impact factor: 2.347

Review 3.  Modified radical hysterectomy: morbidity and mortality.

Authors:  J F Magrina; M A Goodrich; A L Weaver; K C Podratz
Journal:  Gynecol Oncol       Date:  1995-11       Impact factor: 5.482

4.  Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy.

Authors:  K Tewari; F Cappuccini; A Gambino; M F Kohler; S Pecorelli; P J DiSaia
Journal:  Cancer       Date:  1998-04-15       Impact factor: 6.860

Review 5.  Cancer in pregnancy: a review of the literature. Part I.

Authors:  N M Antonelli; D J Dotters; V L Katz; J A Kuller
Journal:  Obstet Gynecol Surv       Date:  1996-02       Impact factor: 2.347

Review 6.  Cervical cancer in pregnancy: reporting on planned delay in therapy.

Authors:  B Duggan; L I Muderspach; L D Roman; J P Curtin; G d'Ablaing; C P Morrow
Journal:  Obstet Gynecol       Date:  1993-10       Impact factor: 7.661

7.  Stage IB cervical carcinoma and pregnancy: report of 49 cases.

Authors:  J A Nisker; M Shubat
Journal:  Am J Obstet Gynecol       Date:  1983-01-15       Impact factor: 8.661

8.  Young age as a prognostic factor in cervical cancer: results of a population-based study.

Authors:  W R Brewster; P J DiSaia; B J Monk; A Ziogas; S D Yamada; H Anton-Culver
Journal:  Am J Obstet Gynecol       Date:  1999-06       Impact factor: 8.661

9.  Invasive cervical cancer complicating intrauterine pregnancy: treatment with radical hysterectomy.

Authors:  B J Monk; F J Montz
Journal:  Obstet Gynecol       Date:  1992-08       Impact factor: 7.661

10.  The prognosis of cervical cancer associated with pregnancy: a matched cohort study.

Authors:  N van der Vange; G J Weverling; B W Ketting; W M Ankum; R Samlal; F B Lammes
Journal:  Obstet Gynecol       Date:  1995-06       Impact factor: 7.661

View more
  1 in total

1.  Cesarean radical hysterectomy for cervical cancer in the United States: a national study of surgical outcomes.

Authors:  Koji Matsuo; Rachel S Mandelbaum; Shinya Matsuzaki; Ernesto Licon; Lynda D Roman; Maximilian Klar; Brendan H Grubbs
Journal:  Am J Obstet Gynecol       Date:  2020-01-23       Impact factor: 8.661

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.